Literature DB >> 10431167

Plaque busters: strategies to inhibit amyloid formation in Alzheimer's disease.

C Soto1.   

Abstract

Alzheimer's disease is a devastating degenerative disorder of the brain for which there is no cure or effective treatment. Although the etiology of Alzheimer's disease is not fully understood, recent research suggests that deposition of cerebral amyloid plaques is central to the disease process. Therefore, an attractive therapeutic strategy for Alzheimer's disease is to prevent, reduce or reverse amyloid deposition in the brain. Several small chemical compounds, synthetic peptides and natural proteins have been described that inhibit amyloid formation or amyloid neurotoxicity in vitro. The effect of these and other compounds now needs to be tested in vivo and the ability of amyloid inhibitors to halt the progression of Alzheimer's disease in humans needs to be evaluated.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10431167     DOI: 10.1016/s1357-4310(99)01508-7

Source DB:  PubMed          Journal:  Mol Med Today        ISSN: 1357-4310


  22 in total

1.  Effects of oligomerization and secondary structure on the surface behavior of pulmonary surfactant proteins SP-B and SP-C.

Authors:  N Wüstneck; R Wüstneck; J Perez-Gil; U Pison
Journal:  Biophys J       Date:  2003-03       Impact factor: 4.033

2.  Quantitative structure-activity relationship analysis of β-amyloid aggregation inhibitors.

Authors:  Shiri Stempler; Michal Levy-Sakin; Anat Frydman-Marom; Yaniv Amir; Roni Scherzer-Attali; Ludmila Buzhansky; Ehud Gazit; Hanoch Senderowitz
Journal:  J Comput Aided Mol Des       Date:  2010-12-17       Impact factor: 3.686

Review 3.  Nanotechnology-based drug delivery systems for targeting, imaging and diagnosis of neurodegenerative diseases.

Authors:  Sibel Bozdağ Pehlivan
Journal:  Pharm Res       Date:  2013-10       Impact factor: 4.200

4.  A liposome-based therapeutic vaccine against beta -amyloid plaques on the pancreas of transgenic NORBA mice.

Authors:  Claude Nicolau; Ruth Greferath; Teodor Silviu Balaban; Jaime E Lazarte; Robert J Hopkins
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-12       Impact factor: 11.205

5.  Contribution by synaptic zinc to the gender-disparate plaque formation in human Swedish mutant APP transgenic mice.

Authors:  Joo-Yong Lee; Toby B Cole; Richard D Palmiter; Sang Won Suh; Jae-Young Koh
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

6.  Computational and experimental studies on β-sheet breakers targeting Aβ1-40 fibrils.

Authors:  Velia Minicozzi; Roberta Chiaraluce; Valerio Consalvi; Cesare Giordano; Claudia Narcisi; Pasqualina Punzi; Giancarlo C Rossi; Silvia Morante
Journal:  J Biol Chem       Date:  2014-02-28       Impact factor: 5.157

7.  Pharmacokinetic Properties of a Novel D-Peptide Developed to be Therapeutically Active Against Toxic β-Amyloid Oligomers.

Authors:  Leonie H E Leithold; Nan Jiang; Julia Post; Tamar Ziehm; Elena Schartmann; Janine Kutzsche; N Jon Shah; Jörg Breitkreutz; Karl-Josef Langen; Antje Willuweit; Dieter Willbold
Journal:  Pharm Res       Date:  2015-09-17       Impact factor: 4.200

8.  Amyloid-beta associated with chitosan nano-carrier has favorable immunogenicity and permeates the BBB.

Authors:  Zhang Songjiang; Wu Lixiang
Journal:  AAPS PharmSciTech       Date:  2009-07-16       Impact factor: 3.246

9.  NAP mechanisms of neuroprotection.

Authors:  Illana Gozes; Ruth A Steingart; Avron D Spier
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

10.  Simultaneous monitoring of peptide aggregate distributions, structure, and kinetics using amide hydrogen exchange: application to Abeta(1-40) fibrillogenesis.

Authors:  Wei Qi; Aming Zhang; Dhara Patel; Sungmun Lee; Jamie L Harrington; Liming Zhao; David Schaefer; Theresa A Good; Erik J Fernandez
Journal:  Biotechnol Bioeng       Date:  2008-08-15       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.